CompletedPhase 4

Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents

France103 participantsStarted 2010-11

Plain-language summary

This study is conducted in Europe. The aim of this study is to compare the easiness of use of Norditropin NordiFlex® device to the device previously used by patients or parents.

Who can participate

Age range6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children who can receive Norditropin® (somatropin) treatment according to the product labelling * Treated with growth hormone for at least one year Exclusion Criteria: * Contraindications to Norditropin® growth hormone therapy * Known or suspected hypersensitivity to somatropin or related products * The receipt of any investigational medicinal product within 3 months prior to study start * Life threatening disease, for example cancer * Pregnancy or the intention of becoming pregnant

What they're measuring

The Relative Ease of Use of NordiFlex® Compared to the Device Previously Used

Timeframe: Week 6

The Relative Ease of Use of NordiFlex® Compared to the Device Previously Used

Timeframe: Week 6

Trial details

NCT IDNCT01245374

SponsorNovo Nordisk A/S

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2011-04

Results submitted2012-04-18

View on ClinicalTrials.gov More Growth Hormone Disorder trials